The buyback is sending a message that goes beyond the numbers. Mutares has fully accepted all bonds tendered in its latest repurchase offer, with further tranches planned over the year. That move carries particular weight given the recent covenant breach that prompted creditors to temporarily suspend their review. The company is effectively putting cash behind its balance-sheet discipline just when skeptics were sharpening their pencils.
Portfolio housekeeping is reinforcing that narrative. Mutares carved out the Dutch distribution arm of its subsidiary F.lli Ferrari, selling it to the HMF Group. The division generated roughly €35 million in revenue and employed about 50 people. Management framed the decision as a sharper focus on in-house crane platforms and own brands. For a company often judged on its ability to accumulate platforms, this selective trimming signals that operational pruning is as much a priority as dealmaking.
The market, however, remains wary. Mutares stock closed Tuesday at €27.45, leaving it down more than eight percent year-to-date and roughly 5.5 percent below the 200-day moving average. The shares have clawed back about 18 percent from the recent trough and are holding the 50-day line, but the 100-day line at €28.93 still looms overhead. A weekly loss of around five percent underscores how fragile the momentum is. The market cap of roughly €593 million leaves room for a re-rating, but technicians want to see a series of bullish signals, not just one.
Should investors sell immediately? Or is it worth buying Mutares?
The next big catalyst could come from Magirus. The firefighting and defense subsidiary booked €85 million in revenue during the first quarter of 2026 and carries an order backlog of €880 million. Mutares is evaluating strategic options including an IPO or a full sale. The recent acquisition of Achleitner Fahrzeugbau has added a defense-vehicle capability that opens access to a European growth market. Any exit here would significantly outpace last year’s total disposal proceeds of €230 million, and management’s 2026 profit forecast of €165 million to €200 million already assumes a material jump in exit income.
Debt reduction is running in parallel. Outstanding liabilities are targeted to shrink from €385 million to €250 million, supported by the bond buybacks and a €105 million capital increase raised in April to fuel U.S. expansion. If the Magirus exit materialises on schedule, the upper end of the earnings guidance comes into clear view. The combination of financial discipline and a well-stocked exit pipeline gives investors a credible counterweight to the skepticism that has weighed on the stock all year.
Ad
Mutares Stock: Buy or Sell?! New Mutares Analysis from June 10 delivers the answer:
The latest Mutares figures speak for themselves: Urgent action needed for Mutares investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 10.
Mutares: Buy or sell? Read more here...
